SEC Form 4 · accession 0001104659-17-021351
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy C Barabe
Director
Period of report
Mar 27, 2017
Accepted (ET)
Apr 4, 2017 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 27, 2017 | M | 2,492 | $11.00 | A | 2,492 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $11.00 | Mar 27, 2017 | M | 2,492 | D | — | Jul 28, 2026 | Common Stock | 2,492 | 10,328 | D |
Explanation of responses
- F1The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant.